Ryoko Sakai
   Department   School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine
   Position  
Article types Original article
Language English
Peer review Peer reviewed
Title Association between patient-reported outcomes and impairments in work and activity in patients with rheumatoid arthritis in clinical remission: a retrospective analysis using the IORRA database.
Journal Formal name:Modern rheumatology
Abbreviation:Mod Rheumatol
ISSN code:14397609/14397595
Volume, Issue, Page Epub ahead of print,pp.-
Author and coauthor Sakai Ryoko, Tanaka Eiichi, Inoue Eisuke, Sato Minako, Tanaka Masaru, Ikari Katsunori, Yamanaka Hisashi, Harigai Masayoshi
Authorship Lead author
Publication date 2022/09
Summary OBJECTIVES:To explore the patient-reported outcomes (PROs) associated with work productivity and activity impairment (WPAI) in patients with rheumatoid arthritis (RA) in clinical remission.METHODS:We enrolled patients with RA ≥18 years and with a simplified disease activity index (SDAI) ≤3.3 from the IORRA dataset collected in October 2017. Pain-visual analogue scale (VAS), patients' global assessment VAS, Japanese version of the Healthcare Assessment Questionnaire-Disability Index (J-HAQ), and duration of morning joint stiffness (MJS) were selected as PROs. To evaluate work productivity and activity, the WPAI-RA instrument (WPAI-RA) was used. To assess the contribution of each PRO to WPAI-RA score, an ANOVA model was constructed.RESULTS:The mean age of the 2,614 patients was 62.4 years; 85.1% were female. Median values of WPAI-RA score were 1.1% for absenteeism, 6.5% for presenteeism, 7.4% for work impairment, and 10.2% for activity impairment. MJS contributed the most to absenteeism (18.0%), while pain-VAS contributed the most to presenteeism (57.4%), work productivity loss (51.1%), and daily activity impairment (53.7%). J-HAQ was the second most contributing factor to presenteeism (17.4%), work productivity loss (16.3%), and daily activity impairment (26.0%).CONCLUSIONS:The pain-VAS and J-HAQ highly contributed to WPAI in patients with RA in clinical remission.
DOI 10.1093/mr/roac105
PMID 36094815